Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
CSL is a global biotechnology company that develops and delivers biotherapies for rare and serious diseases, vaccines, and treatments for iron deficiency and nephrology. Its portfolio includes CSL Behring, CSL Seqirus, and CSL Vifor, addressing conditions such as bleeding disorders, immunodeficiencies, hereditary angioedema, and kidney disease.
Parse Score
